Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101 · see citing works

Cancer Statistics, 2001

Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. J. (2001) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,281 · see citing works

<i>DPC4</i> , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337 · see citing works

Delineation of prognostic biomarkers in prostate cancer

Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R. B., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,675 · see citing works

Is a p53-Regulated Inhibitor of G2/M Progression

Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251 · see citing works

Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126 · see citing works

Specific protection against breast cancers by cyclin D1 ablation

Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · see citing works

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872 · see citing works

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Chang, K., & Pastan, I. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 747 · see citing works

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

Reiter, R. E., Gu, Z., Watabe, T., THOMAS, G. V., Szigeti, K., Davis, E., Wahl, M. I., Nisitani, S., Yamashiro, J. M., Beau, M. M. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 675 · see citing works

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Schutte, M. E. M., Hruban, R. H., Geradts, J., Maynard, R. D., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte‐Waldhoff, I., Schmiegel, W., et al. (1997) · PubMed · Cited by 659 · see citing works

α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer

Rubin, M. A. (2002) · JAMA · doi:10.1001/jama.287.13.1662 · Cited by 648 · see citing works

Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

Wilentz, R. E., Iacobuzio–Donahue, C. A., Argani, P., McCarthy, D. M., Parsons, J. L., Yeo, C. J., Kern, S. E., & Hruban, R. H. (2000) · PubMed · Cited by 591 · see citing works

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Argani, P., Iacobuzio–Donahue, C. A., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E. M., Yeo, C. J., et al. (2001) · PubMed · Cited by 574 · see citing works

Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints

Torhorst, J. K. H., Bucher, C., Kononen, J., Haas, P., Zuber, M., Köchli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M. J., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63075-1 · Cited by 565 · see citing works

14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis

van Hemert, M. J., Steensma, H. Y., & van Heusden, G. P. H. (2001) · BioEssays · doi:10.1002/bies.1134 · Cited by 535 · see citing works

Solid-Pseudopapillary Tumors of the Pancreas Are Genetically Distinct from Pancreatic Ductal Adenocarcinomas and Almost Always Harbor β-catenin Mutations

Abraham, S. C., Klimstra, D. S., Wilentz, R. E., Yeo, C. J., Conlon, K. C., Brennan, M. F., Cameron, J. L., Wu, T., & Hruban, R. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62563-1 · Cited by 487 · see citing works

Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays

Iacobuzio–Donahue, C. A., Maitra, A., Olsen, M. N., Lowe, A. W., van Heek, N. T., Rosty, C., Kim, W., Sato, N., Parker, A. R., Ashfaq, R., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63911-9 · Cited by 471 · see citing works

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., & Kern, S. E. (1994) · PubMed · Cited by 451 · see citing works

High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer

Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A.-T., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444 · see citing works

Tissue microarrays for gene amplification surveys in many different tumor types.

Schraml, P., Kononen, J., Bubendorf, L., Moch, H., Bissig, H., Nocito, A., Mihatsch, M. J., Kallioniemi, O., & Sauter, G. (1999) · PubMed · Cited by 433 · see citing works

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer

Barton, C., Staddon, S., Hughes, C., Hall, P., O'Sullivan, C., Klöppel, G., Theis, B. A., Russell, R. C. G., Neoptolemos, J. P., & Williamson, R. C. N. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.467 · Cited by 375 · see citing works

Genetic progression in the pancreatic ducts

Hruban, R. H., Wilentz, R. E., & Kern, S. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65054-7 · Cited by 373 · see citing works

Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia

van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J. A., Hicks, J. L., Wilentz, R. E., Goggins, M. G., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64432-x · Cited by 363 · see citing works

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

Wilentz, R. E., Geradts, J., Maynard, R. D., Offerhaus, G. J. A., Kang, M., Goggins, M., Yeo, C. J., Kern, S. E., & Hruban, R. H. (1998) · PubMed · Cited by 337 · see citing works

Pancreatic adenocarcinomas frequently show p53 gene mutations.

Scarpa, A., Capelli, P., Mukai, K., Zamboni, G., Oda, T., Iacono, C., & Hirohashi, S. (1993) · PubMed Central · Cited by 332 · see citing works

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

Argani, P., Rosty, C., Reiter, R. E., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Ryu, B., Skinner, H. G., Goggins, M., Jaffee, E. M., et al. (2001) · PubMed · Cited by 313 · see citing works

Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas

Wilentz, R. E., Su, G. H., Dai, J. L., Sparks, A. B., Argani, P., Sohn, T. A., Yeo, C. J., Kern, S. E., & Hruban, R. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64703-7 · Cited by 304 · see citing works

bcl-1, t(11;14), and mantle cell-derived lymphomas [editorial]

Raffeld, M. A., & Jaffe, E. (1991) · Blood · doi:10.1182/blood.v78.2.259.bloodjournal782259 · Cited by 303 · see citing works

Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology

Iacobuzio–Donahue, C. A., Maitra, A., Shen-Ong, G. L. C., van Heek, N. T., Ashfaq, R., Meyer, R., Walter, K., Berg, K. D., Hollingsworth, M. A., Cameron, J. L., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62551-5 · Cited by 294 · see citing works

The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of Carcinogenesis

Adsay, N., Merati, K., Andea, A., Sarkar, F., Hruban, R., Wilentz, R. E., Goggins, M., Iocobuzio-Donahue, C. A., Longnecker, D., & Klimstra, D. (2002) · Modern Pathology · doi:10.1097/01.mp.0000028647.98725.8b · Cited by 290 · see citing works

Genetic and Immunohistochemical Analysis of Pancreatic Acinar Cell Carcinoma

Abraham, S. C., Wu, T., Hruban, R. H., Lee, J.-H., Yeo, C. J., Conlon, K. C., Brennan, M. F., Cameron, J. L., & Klimstra, D. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64917-6 · Cited by 275 · see citing works

Distinctive Molecular Genetic Alterations in Sporadic and Familial Adenomatous Polyposis-Associated Pancreatoblastomas

Abraham, S. C., Wu, T., Klimstra, D. S., Finn, L. S., Lee, J.-H., Yeo, C. J., Cameron, J. L., & Hruban, R. H. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63008-8 · Cited by 272 · see citing works

The Immunohistochemical Mucin Expression Pattern Distinguishes Different Types of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Determines Their Relationship to Mucinous Noncystic Carcinoma and Ductal Adenocarcinoma

Lűttges, J., Zamboni, G., Longnecker, D., & Klöppel, G. (2001) · American Journal of Surgical Pathology · doi:10.1097/00000478-200107000-00014 · Cited by 267 · see citing works

Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.

Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, H., Rau, B., Harada, N., & Beger, H. G. (1997) · PubMed · Cited by 261 · see citing works

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas

Kim, G., Bae, H., Park, H., Kuan, S., Crawley, S., Ho, J. J. L., & Kim, Y. S. (2002) · Gastroenterology · doi:10.1053/gast.2002.36018 · Cited by 252 · see citing works

Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic Carcinogenesis

Luettges, J., Galehdari, H., Bröcker, V., Schwarte‐Waldhoff, I., Henne‐Bruns, D., Klöppel, G., Schmiegel, W., & Hahn, S. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64123-5 · Cited by 241 · see citing works

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma

Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203898 · Cited by 229 · see citing works

Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma

Fukushima, N., Sato, N., Ueki, T., Rosty, C., Walter, K., Wilentz, R. E., Yeo, C. J., Hruban, R. H., & Goggins, M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61104-2 · Cited by 225 · see citing works

Overexpression of p53 Protein in Adenocarcinoma of the Pancreas

DiGiuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M., van den Berg, F. M., Allison, D. C., Cameron, J. L., & Offerhaus, G. J. A. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.6.684 · Cited by 217 · see citing works

BRCA2 Is Inactivated Late in the Development of Pancreatic Intraepithelial Neoplasia

Goggins, M., Hruban, R. H., & Kern, S. E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65047-x · Cited by 213 · see citing works

Expression of mucin antigens in human cancers and its relationship with malignancy potential

Yonezawa, S., & Sato, E. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb03713.x · Cited by 207 · see citing works

Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation.

Østergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H., Orntoft, T. F., Wolf, H., & Celis, J. E. (1997) · PubMed · Cited by 206 · see citing works

Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.

Pandey, P., Kharbanda, S. M., & Kufe, D. W. (1995) · PubMed · Cited by 189 · see citing works

Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.

Ruggeri, B., Zhang, S.-Y., Caamaño, J., DiRado, M., Flynn, S. D., & Klein–Szanto, A. J. (1992) · PubMed · Cited by 172 · see citing works

Genetic Progression and Divergence in Pancreatic Carcinoma

Yamano, M., Fujii, H., Takagaki, T., Kadowaki, N., Watanabe, H., & Shirai, T. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65083-3 · Cited by 160 · see citing works

Cyclooxygenase 2 Expression in Pancreatic Adenocarcinoma and Pancreatic Intraepithelial Neoplasia

Maitra, A., Ashfaq, R., Gunn, C. R., Rahman, A., Yeo, C. J., Sohn, T. A., Cameron, J. L., Hruban, R. H., & Wilentz, R. E. (2002) · American Journal of Clinical Pathology · doi:10.1309/tpg4-ck1c-9v8v-8awc · Cited by 159 · see citing works

Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.

Ryu, B., Jones, J., Blades, N. J., Parmigiani, G., Hollingsworth, M. A., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 154 · see citing works

Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.

Bouras, T., Southey, M. C., Chang, A. C.-M., Reddel, R. R., Willhite, D., Glynne, R. J., Henderson, M. A., Armes, J. E., & Venter, D. J. (2002) · PubMed · Cited by 153 · see citing works

Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer

Grothey, A. F., Hashizume, R., Şahin, A. A., & McCrea, P. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1395 · Cited by 148 · see citing works

Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.

Biankin, A. V., Kench, J. G., Morey, A. L., Lee, C. S. L., Biankin, S. A., Head, D. R., Hugh, T. B., Henshall, S. M., & Sutherland, R. L. (2001) · PubMed · Cited by 148 · see citing works

Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma

Pirinen, R. T., Tammi, R., Tammi, M., Hirvikoski, P. P., Parkkinen, J. J., Johansson, R. T., B�hm, J. P., Hollm�n, S., & Kosma, V. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010120)95:1 · Cited by 146 · see citing works

Expression of MUC1, MUC2, MUC3 and MUC4 mucin mrnas in human pancreatic and intestinal tumor cell lines

Hollingsworth, M. A., Strawhecker, J. M., Caffrey, T. C., & Mack, D. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570212 · Cited by 142 · see citing works

Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: Evidence for multistep carcinogenesis

Apple, S. K., Hecht, J. R., Lewin, D., Jahromi, S. A., Grody, W. W., & Nieberg, R. K. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90265-4 · Cited by 133 · see citing works

Immunohistochemical Validation of a Novel Epithelial and a Novel Stromal Marker of Pancreatic Ductal Adenocarcinoma Identified by Global Expression Microarrays

Maitra, A., Iacobuzio–Donahue, C. A., Rahman, A., Sohn, T. A., Argani, P., Meyer, R., Yeo, C. J., Cameron, J. L., Goggins, M., Kern, S. E., et al. (2002) · American Journal of Clinical Pathology · doi:10.1309/3pam-p5wl-2lv0-r4eg · Cited by 132 · see citing works

Direct Correlation between Proliferative Activity and Dysplasia in Pancreatic Intraepithelial Neoplasia (PanIN): Additional Evidence for a Recently Proposed Model of Progression

Klein, W. M., Hruban, R. H., Klein–Szanto, A. J., & Wilentz, R. E. (2002) · Modern Pathology · doi:10.1038/modpathol.3880544 · Cited by 131 · see citing works

Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers.

Ryu, B., Jones, J., Hollingsworth, M. A., Hruban, R. H., & Kern, S. E. (2001) · PubMed · Cited by 119 · see citing works

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.

Gasco, M., Bell, A. K., Heath, V. L., Sullivan, A., Smith, P., Hiller, L., Yuluğ, I. G., Numico, G., Merlano, M. C., Farrell, P. J., et al. (2002) · PubMed · Cited by 118 · see citing works

Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes.

Kornmann, M., Danenberg, K. D., Arber, N., Beger, H. G., Danenberg, P. V., & Korc, M. (1999) · PubMed · Cited by 113 · see citing works

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors

Hu, W., McCrea, P. D., Deavers, M. T., Kavanagh, J. J., Kudelka, A. P., & Verschraegen, C. F. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1026596609969 · Cited by 107 · see citing works

The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes

Moravski, C. J., Skinner, S. L., Stubbs, A. J., Sarlos, S., Kelly, D. J., Cooper, M. E., Gilbert, R. E., & Wilkinson‐Berka, J. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63806-0 · Cited by 95 · see citing works

SMAD genes in juvenile polyposis

Roth, S., Sistonen, P., Salovaara, R., Hemminki, A., Loukola, A., Johansson, M., Avizienyte, E., Cleary, K., Lynch, P. M., Amos, C. I., et al. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199909)26:1 · Cited by 95 · see citing works

Increased Cyclin D1 in Human Pancreatic Cancer Is Associated with Decreased Postoperative Survival

Kornmann, M., Ishiwata, T., Itakura, J., Tangvoranuntakul, P., Beger, H. G., & Korc, M. (1998) · Oncology · doi:10.1159/000011879 · Cited by 95 · see citing works

Involvement of the MAP kinase ERK2 in MUC1 mucin signaling

Meerzaman, D. M., Shapiro, P. S., & Kim, K. C. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l86 · Cited by 78 · see citing works

Expression of cyclin D1 and retinoblastoma protein in colorectal cancer

Palmqvist, R., Stenling, R., Öberg, Å., & Landberg, G. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00162-2 · Cited by 77 · see citing works

Pathology of incipient pancreatic cancer

Hruban, R. H., Wilentz, R. E., Goggins, M., Offerhaus, G. J. A., Yeo, C. J., & Kern, S. E. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s9 · Cited by 76 · see citing works

Analysis of β-Catenin Gene Mutations in Pancreatic Tumors

Gerdes, B., Ramaswamy, A., Simon, B., Pietsch, T., Bastian, D., Kersting, M., Moll, R., & Bartsch, D. K. (1999) · Digestion · doi:10.1159/000007704 · Cited by 74 · see citing works

Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.

Zhang, S. Y., Ruggeri, B., Agarwal, P., Sorling, A. F., Obara, T., Ura, H., Namiki, M., & Klein–Szanto, A. J. (1994) · PubMed · Cited by 73 · see citing works

Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.

Hassan, R., Lerner, M. R., Benbrook, D. M., Lightfoot, S. A., Brackett, D. J., Wang, Q.-C., & Pastan, I. H. (2002) · PubMed · Cited by 70 · see citing works

Prevention of Pancreatic Cancer and Strategies for Management of Familial Pancreatic Cancer

Hruban, R. H., Canto, M. I., & Yeo, C. J. (2001) · Digestive Diseases · doi:10.1159/000050656 · Cited by 61 · see citing works

REVIEW ARTICLE. p53: GUARDIAN OF CELLULAR SENESCENCE

Wynford‐Thomas, D. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199610)180:2 · Cited by 59 · see citing works

Pathology of Cancer of the Pancreas

Wilentz, R. E., & Hruban, R. H. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30284-9 · Cited by 50 · see citing works

Epidermal Growth Factor Induces Cyclin D1 in Human Pancreatic Carcinoma: Evidence for a Cyclin D1–Dependent Cell Cycle Progression

Poch, B., Gansauge, F., Schwarz, A., Seufferlein, T. T. W., Schnelldorfer, T., Ramadani, M., Beger, H. G., & Gansauge, S. (2001) · Pancreas · doi:10.1097/00006676-200110000-00009 · Cited by 48 · see citing works

Aberrant Expression of Tumor Suppressor Proteins in the Ewing Family of Tumors

Maitra, A., Roberts, H., Weinberg, A. G., & Geradts, J. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-1207-aeotsp · Cited by 48 · see citing works

HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: Risk factors and impact on survival

Melbye, M., Poulsen, A.-G., Gallo, D., Pedersen, J. B., Biggar, R. J., Larsen, O., Dias, F., & Aaby, P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980504)76:3 · Cited by 42 · see citing works

Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxin.

Fan, D., Yano, S., Shinohara, H., Solórzano, C. C., Arsdall, M. R. V., Bucana, C. D., Pathak, S., Kruzel, E., Herbst, R. S., Onn, A., et al. (2002) · PubMed · Cited by 42 · see citing works

Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors.

de Bolós, C. (2001) · Frontiers in bioscience · doi:10.2741/bolos · Cited by 37 · see citing works

Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.

Mäkinen, K., Hakala, T., Lipponen, P., ALHAVA, E. M., & Eskelinen, M. J. (1998) · PubMed · Cited by 34 · see citing works

The Expression of Cyclins D1 and E in Predicting Short-Term Survival in Squamous Cell Carcinoma of the Lung

Anton, R. C., Coffey, D. M., Gondo, M., Stephenson, M. A., Brown, R. W., & Cagle, P. T. (2000) · Modern Pathology · doi:10.1038/modpathol.3880215 · Cited by 32 · see citing works

Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material

Linder, S., Parrado, C., Falkmer, S., Blåsjö, M., Sundelin, P., & von Rosen, A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.336 · Cited by 32 · see citing works

De novo Expression of the Muc2 Gene in Pancreas Carcinoma Cells Is Triggered by Promoter Demethylation

Siedow, A., Moshe Szyf, A., Gratchev, A. N., Kobalz, U., Hanski, M. L., Bumke‐Vogt, C., Foss, H., Riecken, E. O., & HANSKI, C. (2002) · Tumor Biology · doi:10.1159/000048689 · Cited by 26 · see citing works

Regulation of mucin and glycoconjugate expression from normal epithelium to gastric tumors

de Bolós, C. (2001) · Frontiers in bioscience · doi:10.2741/a678 · Cited by 8 · see citing works

Pancreatic cancer

Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212 · see citing works

Genetics and biology of pancreatic ductal adenocarcinomaPreprint

Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,570 · see citing works

Pancreatic cancer: Advances and challenges

Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works

An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms

Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091 · see citing works

Phenotype and Genotype of Pancreatic Cancer Cell Lines

Deer, E. L., González-Hernández, J., Coursen, J. D., Shea, J. E., Ngatia, J., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c15963 · Cited by 936 · see citing works

Pancreatic Cancer

Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707 · see citing works

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

Morton, J. P., Timpson, P., Karim, S. A., Ridgway, R. A., Athineos, D., Doyle, B., Jamieson, N. B., Oien, K. A., Lowy, A. M., Brunton, V. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908428107 · Cited by 657 · see citing works

Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

Bardeesy, N. M., Aguirre, A. J., Chu, G. C., Cheng, K., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C. W., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 575 · see citing works

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

Morris, J. P., Wang, S. C., & Hebrok, M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2899 · Cited by 567 · see citing works

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Gironella, M., Seux, M., Xie, M.-J., Cano, C. E., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 548 · see citing works

Independence and reproducibility across microarray platforms

Larkin, J. E., Frank, B. C., Gavras, H. P., Sultana, R., & Quackenbush, J. F. (2005) · Nature Methods · doi:10.1038/nmeth757 · Cited by 420 · see citing works

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

Iacobuzio–Donahue, C. A., Ashfaq, R., Maitra, A., Adsay, V. N., Shen-Ong, G. L. C., Berg, K. D., Hollingsworth, M. A., Cameron, J. L., Yeo, C. J., Kern, S. E., et al. (2003) · PubMed · Cited by 415 · see citing works

Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma

Infante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. S., Yeo, C. J., Iacobuzio–Donahue, C. A., & Goggins, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8824 · Cited by 403 · see citing works

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N., & Nakagawa, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605570 · Cited by 324 · see citing works

Stromal biology of pancreatic cancer

Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 321 · see citing works

Hedgehog/Ras interactions regulate early stages of pancreatic cancerPreprint

di Magliano, M. P., Sekine, S., Ermilov, A. N., Ferris, J., Dlugosz, A. A., & Hebrok, M. (2006) · Genes & Development · doi:10.1101/gad.1470806 · Cited by 302 · see citing works

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

Habbe, N., Koorstra, J.-B. M., Mendell, J. T., Offerhaus, G. J. A., Ryu, J. K., Feldmann, G., Mullendore, M. E., Goggins, M., Hong, S., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.4.7338 · Cited by 296 · see citing works

Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes

Mino-Kenudson, M. A., Castillo, C. F.-D., Baba, Y., Valsangkar, N. P., Liss, A. S., Hsu, M., Correa‐Gallego, C., Ingkakul, T., Johnston, R. P., Turner, B. G., et al. (2011) · Gut · doi:10.1136/gut.2010.232272 · Cited by 292 · see citing works

Precursors to Invasive Pancreatic Cancer

Maitra, A., Fukushima, N., Takaori, K., & Hruban, R. H. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000155055.14238.25 · Cited by 290 · see citing works

Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker?

Hashimoto, Y., Skacel, M., & Adams, J. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.004 · Cited by 275 · see citing works

Molecular genetics of pancreatic intraepithelial neoplasia

Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269 · see citing works

Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases

Pommier, A., Anaparthy, N., Memos, N. K., Kelley, Z. L., Gouronnec, A., Yan, R., Auffray, C., Albrengues, J., Egeblad, M., Iacobuzio–Donahue, C. A., et al. (2018) · Science · doi:10.1126/science.aao4908 · Cited by 269 · see citing works

A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice

Philip, B., Roland, C. L., Daniluk, J., Liu, Y., Chatterjee, D., Gomez, S., Ji, B., Huang, H., Wang, H., Fleming, J. B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.018 · Cited by 249 · see citing works

Update on pancreatic intraepithelial neoplasia.

Hruban, R. H., Maitra, A., & Goggins, M. (2008) · PubMed Central · Cited by 245 · see citing works

Gene Expression Profiles in Pancreatic Intraepithelial Neoplasia Reflect the Effects of Hedgehog Signaling on Pancreatic Ductal Epithelial Cells

Prasad, N. B., Biankin, A. V., Fukushima, N., Maitra, A., Dhara, S., ELKAHLOUN, A. G., Hruban, R. H., Goggins, M., & Leach, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1413 · Cited by 240 · see citing works

Molecular Pathogenesis of Pancreatic Cancer

Grant, T. J., Hua, K., & Singh, A. (2016) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.09.008 · Cited by 237 · see citing works

Pancreatic cancer microenvironment

Kleeff, J. H., Beckhove, P., Esposito, I., Herzig, S., Huber, P. E., Löhr, M. J., & Friess, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22871 · Cited by 222 · see citing works

Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells

Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2678 · Cited by 220 · see citing works

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN

Distler, M., Aust, D. E., Weitz, J., Pilarsky, C. P., & Grützmann, R. (2014) · BioMed Research International · doi:10.1155/2014/474905 · Cited by 219 · see citing works

Intraductal Tubulopapillary Neoplasms of the Pancreas Distinct From Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms

Yamaguchi, H., Shimizu, M., Ban, S., Koyama, I., Hatori, T., Fujita, I., Yamamoto, M., Kawamura, S., Kobayashi, M., Ishida, K., et al. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181a162e5 · Cited by 213 · see citing works

MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias

Yu, J., Li, A., Hong, S., Hruban, R. H., & Goggins, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2347 · Cited by 212 · see citing works

Molecular pathogenesis of pancreatic cancer

Maitra, A., Kern, S. E., & Hruban, R. H. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.002 · Cited by 199 · see citing works

Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions

Buchholz, M., Braun, M., Heidenblut, A., Kestler, H. A., Klöppel, G., Schmiegel, W., Hahn, S. A., Lüttges, J., Gress, T. M., & Krebshilfe, F. T. G. P. C. N. O. T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208804 · Cited by 190 · see citing works

Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features

Omori, Y., Ono, Y., Tanino, M. A., Karasaki, H., Yamaguchi, H., Furukawa, T., Enomoto, K., Ueda, J., Sumi, A., Katayama, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.029 · Cited by 189 · see citing works

Pancreatic Carcinogenesis

Koorstra, J.-B. M., Hustinx, S. R., Offerhaus, G. J. A., & Maitra, A. (2008) · Pancreatology · doi:10.1159/000123838 · Cited by 180 · see citing works

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

Li, M., Bharadwaj, U., Zhang, R., Zhang, S., Mu, H. H., Fisher, W. E., Brunicardi, F. C., Chen, C., & Yao, Q. C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0483 · Cited by 178 · see citing works

Proteomic Analysis of Chronic Pancreatitis and Pancreatic Adenocarcinoma

Crnogorac‐Jurcevic, T., Gangeswaran, R., Bhakta, V., Capurso, G., Lattimore, S., Akada, M., Sunamura, M., Prime, W., Campbell, F., Brentnall, T. A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.012 · Cited by 170 · see citing works

Mucin expression profile in pancreatic cancer and the precursor lesions

Nagata, K., Horinouchi, M., Saitou, M., Higashi, M., Nomoto, M., Goto, M., & Yonezawa, S. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1169-2 · Cited by 167 · see citing works

Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: Its Histopathologic Difference Between 2 Major Types

Ban, S., Naitoh, Y., Mino-Kenudson, M. A., Sakurai, T., Kuroda, M., Koyama, I., Lauwers, G. Y., & Shimizu, M. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213305.98187.d4 · Cited by 165 · see citing works

Pancreatic Duct Glands Are Distinct Ductal Compartments That React to Chronic Injury and Mediate Shh-Induced Metaplasia

Strobel, O., Rosow, D. E., Rakhlin, E. Y., Lauwers, G. Y., Trainor, A. G., Alsina, J., del Castillo, C. F., Warshaw, A. L., & Thayer, S. P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.12.005 · Cited by 162 · see citing works

Pathology and Molecular Genetics of Pancreatic Neoplasms

Wood, L. D., & Hruban, R. H. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827459b6 · Cited by 161 · see citing works

Genetic analyses of isolated high‐grade pancreatic intraepithelial neoplasia (HG‐PanIN) reveal paucity of alterations in TP53 and SMAD4

Hosoda, W., Chianchiano, P. E., Griffin, J. F., Pittman, M. E., Brosens, L. A. A., Noë, M., Yu, J., Shindo, K., Suenaga, M., Rezaee, N., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4884 · Cited by 158 · see citing works

Barriers and opportunities for gemcitabine in pancreatic cancer therapy

Beutel, A. K., & Halbrook, C. J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2022 · Cited by 150 · see citing works

Precursor Lesions of Pancreatic Cancer: Molecular Pathology and Clinical Implications

Singh, M., & Maitra, A. (2007) · Pancreatology · doi:10.1159/000101873 · Cited by 148 · see citing works

Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1

Seki (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.919 · Cited by 145 · see citing works

Genetically Engineered Mouse Models of Pancreatic Cancer

Westphalen, C. B., & Olive, K. P. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827ab4c4 · Cited by 140 · see citing works

Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma

Ryu, J. K., Hong, S., Karikari, C. A., Hruban, R. H., Goggins, M., & Maitra, A. (2010) · Pancreatology · doi:10.1159/000231984 · Cited by 140 · see citing works

Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer

Teng, K., Mansour, A. G., Zhu, Z. G., Li, Z., Tian, L., Ma, S., Xu, B., Lu, T., Chen, H., Hou, D., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.281 · Cited by 136 · see citing works

Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas

Hashimoto, Y., Skacel, M., Lavery, I. C., Mukherjee, A. L., Casey, G., & Adams, J. C. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-241 · Cited by 130 · see citing works

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment

Sukumaran, S., Watanabe, N., Bajgain, P., Raja, K., Mohammed, S., Fisher, W. E., Brenner, M. K., Leen, A. M., & Vera, J. F. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1298 · Cited by 128 · see citing works

Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas

Furukawa, T., Fujisaki, R., Yoshida, Y., Kanai, N., Sunamura, M., Abe, T., Takeda, K., Matsuno, S., & Horii, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800383 · Cited by 128 · see citing works

Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion

Hustinx, S. R., Leoni, L. M., Yeo, C. J., Brown, P. N., Goggins, M., Kern, S. E., Hruban, R. H., & Maitra, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800377 · Cited by 125 · see citing works

Perspectives on c-Myc, Cyclin D1, and Their Interaction in Cancer Formation, Progression, and Response to Chemotherapy

Liao, D. J., Thakur, A. B., Wu, J., Biliran, H., & Sarkar, F. H. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i2.10 · Cited by 116 · see citing works

Pancreatic Intraepithelial Neoplasia

Takaori, K., Hruban, R. H., Maitra, A., & Tanigawa, N. (2004) · Pancreas · doi:10.1097/00006676-200404000-00008 · Cited by 116 · see citing works

Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions

Brunner, M., Wu, Z., Krautz, C., Pilarsky, C. P., Grützmann, R., & Weber, G. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184543 · Cited by 115 · see citing works

Fascin Is Regulated by Slug, Promotes Progression of Pancreatic Cancer in Mice, and Is Associated With Patient Outcomes

Li, A., Morton, J. P., Ma, Y., Karim, S. A., Zhou, Y., Faller, W. J., Woodham, E. F., Morris, H., Stevenson, R. P., Juin, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.046 · Cited by 114 · see citing works

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis

Haque, I., Mehta, S., Majumder, M., Dhar, K., De, A., McGregor, D., Van Veldhuizen, P. J., Banerjee, S. K., & Banerjee, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-8 · Cited by 113 · see citing works

Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras‐MAPK signaling

Herner, A., Sauliunaite, D., Michalski, C. W., Erkan, M., Oliveira, T. D., Abiatari, I., Kong, B., Esposito, I., Frieß, H., & Kleeff, J. H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25898 · Cited by 113 · see citing works

Overexpression of the Nuclear Receptor Coactivator AIB1 ( SRC-3 ) during Progression of Pancreatic Adenocarcinoma

Henke, R. T., Haddad, B. R., Kim, S. E., Rone, J. D., Mani, A., Jessup, J. M., Wellstein, A., Maitra, A., & Riegel, A. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0561 · Cited by 113 · see citing works

Pancreatic Intraepithelial Neoplasia Revisited and Updated

Sipos, B., Frank, S., Gress, T. M., Hahn, S. A., & Klöppel, G. (2008) · Pancreatology · doi:10.1159/000178874 · Cited by 112 · see citing works

Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis

Tanaka, M. H., Shibahara, J., Fukushima, N., Shinozaki‐Ushiku, A., Umeda, M., Ishikawa, S., Kokudo, N., & Fukayama, M. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411420569 · Cited by 107 · see citing works

MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma

Tinder, T. L., Subramani, D. B., Basu, G. D., Bradley, J. M., Schettini, J. L., Arefayene, M., Skaar, T. C., & Mukherjee, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3116 · Cited by 106 · see citing works

Mesothelin-Induced Pancreatic Cancer Cell Proliferation Involves Alteration of Cyclin E via Activation of Signal Transducer and Activator of Transcription Protein 3

Bharadwaj, U., Li, M., Chen, C., & Yao, Q. C. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0095 · Cited by 106 · see citing works

Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells

Merlin, J., Stechly, L., de Beauce, S., Monté, D., Leteurtre, E., SEUNINGEN, I. V., Huet, G., & Pigny, P. (2011) · Oncogene · doi:10.1038/onc.2010.631 · Cited by 105 · see citing works

K‐Ras and microsatellite marker analysis of fine‐needle aspirates from intraductal papillary mucinous neoplasms of the pancreas

Schoedel, K. E., Finkelstein, S. D., & Ohori, N. P. (2006) · Diagnostic Cytopathology · doi:10.1002/dc.20511 · Cited by 105 · see citing works

Histopathological Diagnosis of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary-Mucinous Neoplasms: Interobserver Agreement

Longnecker, D. S., Adsay, V. N., Castillo, C. F. F.-D., Hruban, R. H., Kasugai, T., Klimstra, D. S., Kl??ppel, G., L�ttges, J., Memoli, V. A., Tosteson, T. D., et al. (2005) · Pancreas · doi:10.1097/01.mpa.0000186245.35716.18 · Cited by 102 · see citing works

Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo

Qiu, W., Sahin, F., Iacobuzio-Donahue, C. A., Garcia-Carracedo, D., Wang, W. M., Kuo, C.-Y., Chen, D., Arking, D. E., Lowy, A. M., Hruban, R. H., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.357 · Cited by 99 · see citing works

Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways

Cao, D., Maitra, A., Saavedra, J.-A., Klimstra, D. S., Adsay, V. N., & Hruban, R. H. (2005) · Modern Pathology · doi:10.1038/modpathol.3800363 · Cited by 98 · see citing works

SMAD4 and its role in pancreatic cancer

Xia, X., Wu, W., Huang, C., Cen, G., Jiang, T., Cao, J., Huang, K., & Qiu, Z. (2014) · Tumor Biology · doi:10.1007/s13277-014-2883-z · Cited by 97 · see citing works

Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma

Xue, L., Hu, N., Song, Y., Zou, S., Shou, J., Qian, L.-X., Ren, L.-Q., Lin, D., Tong, T., He, Z.-G., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-296 · Cited by 95 · see citing works

Pancreatic Intraepithelial Neoplasia in Association With Intraductal Papillary Mucinous Neoplasms of the Pancreas

Biankin, A. V., Kench, J. G., Biankin, S. A., Lee, C.-S., Morey, A. L., Dijkman, F. P., Coleman, M. J., Sutherland, R. L., & Henshall, S. M. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000131556.22382.3c · Cited by 94 · see citing works

CEACAM6 Is a Novel Biomarker in Pancreatic Adenocarcinoma and PanIN Lesions

Duxbury, M. S., Matros, E., Clancy, T. E., Bailey, G., Doff, M., Zinner, M. J., Ashley, S. W., Maitra, A., Redston, M. S., & Whang, E. E. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000154455.86404.e9 · Cited by 94 · see citing works

PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma

Gold, D. V., Karanjawala, Z., Modrak, D. E., Goldenberg, D. M., & Hruban, R. H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1488 · Cited by 93 · see citing works

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer

Giovannetti, E., Mey, V., Nannizzi, S., Pasqualetti, G., Tacca, M. D., & Danesi, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0004 · Cited by 93 · see citing works

Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies

Ruarus, A. H., Vroomen, L. G. P. H., Puijk, R. S., Scheffer, H. J., & Meijerink, M. R. (2018) · Cancers · doi:10.3390/cancers10010016 · Cited by 87 · see citing works

High mesothelin expression in advanced lung adenocarcinoma is associated withKRASmutations and a poor prognosis

Thomas, A., Chen, Y., Steinberg, S. M., Luo, J., Pack, S., Raffeld, M. A., Abdullaev, Z., Alewine, C., Rajan, A., Giaccone, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3429 · Cited by 84 · see citing works

Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: Etiopathogenic similarities, differences and paradoxes

Porta, M. S., Crous‐Bou, M., Wark, P. A., Vineis, P., Real, F. X., Malats, N., & Kampman, E. (2009) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2009.07.003 · Cited by 83 · see citing works

Precursor lesions in pancreatic cancer: morphological and molecular pathology

Scarlett, C. J., Salisbury, E., Biankin, A. V., & Kench, J. G. (2011) · Pathology · doi:10.1097/pat.0b013e3283445e3a · Cited by 82 · see citing works

Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis

Mihaljević, A. L., Michalski, C. W., Friess, H., & Kleeff, J. H. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0622-5 · Cited by 81 · see citing works

Molecular Genetics of Pancreatic Neoplasms and Their Morphologic Correlates

Reid, M. D., Saka, B., Balcı, S., Goldblum, A., & Adsay, V. N. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcp0fkdp7envkev · Cited by 80 · see citing works

Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder

Tong, G., Yee, H. T., Chiriboga, L. A., Hernandez, O. J., & Waisman, J. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.005 · Cited by 80 · see citing works

The Mdm network and its regulation of p53 activities: a rheostat of cancer risk

Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79 · see citing works

Current and future biomarkers for pancreatic adenocarcinoma

Loosen, S. H., Neumann, U. P., Trautwein, C., Roderburg, C., & Luedde, T. (2017) · Tumor Biology · doi:10.1177/1010428317692231 · Cited by 78 · see citing works

Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.

Zhang, X., Shi, S., Zhang, B., Ni, Q., Yu, X., & Xu, J. (2018) · PubMed Central · Cited by 78 · see citing works

Inactivation of Brca2 Promotes Trp53-Associated but Inhibits KrasG12D-Dependent Pancreatic Cancer Development in Mice

Rowley, M., Ohashi, A., Mondal, G., Mills, L., Yang, L., Zhang, L., Sundsbak, R. S., Shapiro, V. S., Muders, M. H., Smyrk, T. C., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.039 · Cited by 77 · see citing works

Genetic Progression of Pancreatic Cancer

Cowan, R. W., & Maitra, A. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000011 · Cited by 76 · see citing works

Targeting Mechanoresponsive Proteins in Pancreatic Cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14

Surcel, A., Schiffhauer, E. S., Thomas, D. G., Zhu, Q., DiNapoli, K. T., Herbig, M., Otto, O., West‐Foyle, H., Jacobi, A., Kräter, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3131 · Cited by 76 · see citing works

Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma

McIntyre, C. A., Lawrence, S., Richards, A. L., Chou, J. F., Wong, W., Capanu, M., Berger, M. F., Donoghue, M. T. A., Yu, K. H., Varghese, A. M., et al. (2020) · Cancer · doi:10.1002/cncr.33038 · Cited by 75 · see citing works

Biliary intraepithelial neoplasia in patients without chronic biliary disease

Wu, T., Levy, M. L., Correa, A. M., Rosen, C. B. B., & Abraham, S. C. (2009) · Cancer · doi:10.1002/cncr.24471 · Cited by 74 · see citing works

Analysis of the Pancreatic Tumor Progression by a Quantitative Proteomic Approach and Immunhistochemical Validation

Sitek, B., Sipos, B., Alkatout, İ., Poschmann, G., Stephan, C., Schulenborg, T., Marcus, K., Lüttges, J., Dittert, D., Baretton, G. B., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr800890j · Cited by 73 · see citing works

Clinical importance of precursor lesions in the pancreas

Hruban, R. H., Takaori, K., Canto, M. I., Fishman, E. K., Campbell, K. A., Brune, K. A., Kern, S. E., & Goggins, M. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1170-9 · Cited by 73 · see citing works

Heterogeneity and Targeting of Pancreatic Cancer Stem Cells

Penchev, V. R., Rasheed, Z. A., Maitra, A., & Matsui, W. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3112 · Cited by 72 · see citing works

Mouse models of pancreatic cancer

Leach, S. D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00337-4 · Cited by 72 · see citing works

Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice

Kimura, K., Satoh, K., Kanno, A., Hamada, S., Hirota, M., Endoh, M., Masamune, A., & Shimosegawa, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00369.x · Cited by 72 · see citing works

Deciphering the role of hedgehog signaling in pancreatic cancer

Gu, D., Kelly, E., & Xie, J. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.30.20150107 · Cited by 70 · see citing works

Claudin-4, Mitogen-Activated Protein Kinase Kinase 4, and Stratifin Are Markers of Gastric Adenocarcinoma Precursor Lesions

Cunningham, S. C., Kamangar, F., Kim, M. P., Hammoud, S., Haque, R. M., Iacobuzio–Donahue, C. A., Maitra, A., Ashfaq, R., Hustinx, S. R., Heitmiller, R. E., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0539 · Cited by 70 · see citing works

Loss of WISP-2/CCN5 signaling in human pancreatic cancer: A potential mechanism for epithelial-mesenchymal-transition

Dhar, G., Mehta, S., Banerjee, S., Gardner, A., McCarty, B. M., Mathur, S. C., Campbell, D. R., Kambhampati, S., & Banerjee, S. K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.02.012 · Cited by 69 · see citing works

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

Dunne, R. F., & Hezel, A. F. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.04.003 · Cited by 67 · see citing works

Pharmacological activation of myosin II paralogs to correct cell mechanics defects

Surcel, A., Ng, W. P., West‐Foyle, H., Zhu, Q., Ren, Y., Avery, L. B., Krenc, A. K., Meyers, D. J., Rock, R. S., Anders, R. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412592112 · Cited by 67 · see citing works

Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration

Chen, Y., Zheng, B., Robbins, D. H., Lewin, D., Mikhitarian, K., Graham, A. S., Rumpp, L., Glenn, T. F., Gillanders, W. E., Cole, D. J., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22487 · Cited by 66 · see citing works

Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions

Buchholz, M., Braun, M., Heidenblut, A., Kestler, H. A., Klöppel, G., Schmiegel, W., Hahn, S. A., Lüttges, J., Gress, T. M., & Krebshilfe, F. T. G. P. C. N. O. T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208804 · Cited by 190 · see citing works

Pancreatic intra-epithelial neoplasia: current clinicopathological and molecular considerations

Andea, A. A., Baştürk, O., & Adsay, V. N. (2005) · Current Diagnostic Pathology · doi:10.1016/j.cdip.2004.11.008 · Cited by 2 · see citing works

MUC4 Expression Increases Progressively in Pancreatic Intraepithelial Neoplasia

Swartz, M. J., Batra, S. K., Varshney, G. C., Hollingsworth, M. A., Yeo, C. J., Cameron, J. L., Wilentz, R. E., Hruban, R. H., & Argani, P. (2002) · American Journal of Clinical Pathology · doi:10.1309/7y7n-m1wm-r0yk-m2va · Cited by 238 · see citing works

Update on pancreatic intraepithelial neoplasia.

Hruban, R. H., Maitra, A., & Goggins, M. (2008) · PubMed Central · Cited by 245 · see citing works

Molecular genetics of pancreatic intraepithelial neoplasia

Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269 · see citing works